200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Reports Fourth-Quarter and Full-Year 2025 Financial Results
First Amendment to Research Agreement with Roche Signed by Madrigal
Rita Thakkar Appointed Senior VP and Chief Accounting Officer
Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates
Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist
Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH
Shareholder votes
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence